文献速递细菌感染、耐药与抗菌药物

嘌呤生物合成抑制因子PurR参与实验性心内膜炎中耐甲氧西林金黄色葡萄球菌对万古霉素的敏感性

The Purine Biosynthesis Repressor, PurR, Contributes to Vancomycin Susceptibility of Methicillin-resistant Staphylococcus aureus in Experimental Endocarditis.
PubMed 文献 · J Infect Dis · 2024-01-01

本研究在实验性感染性心内膜炎模型中探讨嘌呤生物合成抑制因子PurR对耐甲氧西林金黄色葡萄球菌(MRSA)毒力因子表达及万古霉素(VAN)疗效的影响。结果显示purR突变株中purF表达增强、嘌呤中间代谢产物增多,sigB、sarA及其下游毒力基因(如fnbA、hla)表达上调,fnbA/fnbB转录增强使纤连蛋白黏附增加;VAN治疗后purR突变株在靶组织中的MRSA负荷未显著降低。作者认为嘌呤生物合成通路与毒力因子表达协调及VAN治疗期间体内持续存在相关,可能为靶向MRSA的新型抗菌药物开发提供途径。

要点

  • purR突变株中purF表达增强且嘌呤中间代谢产物增多,证实PurR介导嘌呤生物合成抑制。
  • purR突变株在体外及感染心脏赘生物中sigB、sarA及下游毒力基因fnbA、hla表达增强。
  • VAN治疗后purR突变株在靶组织中MRSA负荷未显著降低,作者认为该通路可能为新型抗菌药物开发提供途径。

核心结论

  • 作者认为嘌呤生物合成通路与毒力因子表达协调及VAN治疗期间体内持续存在相关,可能为靶向MRSA的新型抗菌药物开发提供途径。

研究设计与样本

  • 在实验性感染性心内膜炎模型中研究嘌呤生物合成抑制因子PurR在MRSA毒力因子表达和万古霉素治疗结局中的作用。

主要发现

  • purR突变株中purF表达增强且嘌呤中间代谢产物增多,证实PurR介导的嘌呤生物合成抑制。
  • purR突变株在体外及感染心脏赘生物中sigB、sarA及其下游毒力基因(如fnbA、hla)表达增强。
  • purR缺陷增强fnbA/fnbB转录,使纤连蛋白黏附较野生型和purR互补株增加。
  • 在感染性心内膜炎模型中,VAN治疗后purR突变株在靶组织中的MRSA负荷未显著降低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Staphylococcus aureus is the most common cause of life-threatening endovascular infections, including infective endocarditis (IE). These infections, especially when caused by methicillin-resistant strains (MRSA), feature limited therapeutic options and high morbidity and mortality rates. METHODS: Herein, we investigated the role of the purine biosynthesis repressor, PurR, in virulence factor expression and vancomycin (VAN) treatment outcomes in experimental IE due to MRSA. RESULTS: The PurR-mediated repression of purine biosynthesis was confirmed by enhanced purF expression and production of an intermediate purine metabolite in purR mutant strain. In addition, enhanced expression of the transcriptional regulators, sigB and sarA, and their key downstream virulence genes (eg, fnbA, and hla) was demonstrated in the purR mutant in vitro and within infected cardiac vegetations. Furthermore, purR deficiency enhanced fnbA/fnbB transcription, translating to increased fibronectin adhesion versus the wild type and purR-complemented strains. Notably, the purR mutant was refractory to significant reduction in target tissues MRSA burden following VAN treatment in the IE model. CONCLUSIONS: These findings suggest that the purine biosynthetic pathway intersects the coordination of virulence factor expression and in vivo persistence during VAN treatment, and may represent an avenue for novel antimicrobial development targeting MRSA.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Xiong YQ, Li Y, Goncheva MI, et al. The Purine Biosynthesis Repressor, PurR, Contributes to Vancomycin Susceptibility of Methicillin-resistant Staphylococcus aureus in Experimental Endocarditis. J Infect Dis. 2024. PMID: 38297970. doi:10.1093/infdis/jiad577

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。